Research on gene expression regulated by long-term erythromycin therapy for chronic respiratory disease

Research on gene expression regulated by long-term erythromycin therapy for chronic respiratory disease - Research on gene expression regulated by long-term erythromycin therapy for chronic respiratory disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022281

Enrollment

Registered

2016-05-11

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic respiratory disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with chronic respiratory disease 2)Patients start to receive long-term erythromycin therapy

Exclusion criteria

Exclusion criteria: 1)Patients who change their medicine except for erythromycin 1 month before treatment and 4~8 weeks after treatment 2)Patients who need to receive standard of care

Design outcomes

Primary

Measure	Time frame
regulation of gene expression after 4~8 weeks treatment	—

Countries

Japan

Contacts

Public ContactKozo Morimoto

Fukujuji Hospital Japan Anti-Tuberculosis Association Respiratory Disease Center

morimotok@fukujuji.org042-491-4111

Outcome results